Maria Pia Grassi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maria Pia Grassi has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Alfonso Mangoni
1 shared publicationCecilia Perin
1 shared publicationMonica Borella
1 shared publication
Latest Publications
- 1 November 1999
- Published by S. Karger AG in European Neurology
- Vol. 42 (4) , 225-229
Assessment of Cognitive Function in Asymptomatic HIV-Positive Subjects
This retrospective study aims to assess cognitive involvement in pre-AIDS, not drug abuser subjects and to determine whether CD4 status or disease stage best correlates with cognitive changes that may portend development of ADC. 328 cases were analyzed. No differences in psychometric performance in relation to CDC stage were found. Instead, patients with CD4 < 200/μl performed worse overall, with a statistically significant difference for Digit Symbol, Corsi Test, Block Design and HIVDA Scale. Even if cognitive decline is not evident in the early phase of HIV infection, CD4 count seems the more sensitive early indicator of cognitive changes adequately pointed out by the HIVDA Scale, which could be considered a useful screening tool for cognitive deficit.
- 1 November 1999
- Published by S. Karger AG in European Neurology
- Vol. 42 (4) , 225-229
Assessment of Cognitive Function in Asymptomatic HIV-Positive Subjects
This retrospective study aims to assess cognitive involvement in pre-AIDS, not drug abuser subjects and to determine whether CD4 status or disease stage best correlates with cognitive changes that may portend development of ADC. 328 cases were analyzed. No differences in psychometric performance in relation to CDC stage were found. Instead, patients with CD4 < 200/μl performed worse overall, with a statistically significant difference for Digit Symbol, Corsi Test, Block Design and HIVDA Scale. Even if cognitive decline is not evident in the early phase of HIV infection, CD4 count seems the more sensitive early indicator of cognitive changes adequately pointed out by the HIVDA Scale, which could be considered a useful screening tool for cognitive deficit.